Brief: Anika Therapeutics Q1 Revenue USD 40.523 Million
08/05/2024 21:06
May 08 (Reuters) - Anika Therapeutics Q1 gross profit USD 24.628 million. * Q1 pretax profit USD -4.471 million * Q1 income from operations USD -5.063 million * Q1 net income USD -4.514 million